arrow
Back
V

Veronique de Jager

Uppsala University

12H-index
38Paper Count
548Citation Count
Published Papers 21
Publication Date
Safety and immunogenicity of DNA omicron booster Alveavax-v1.2 in Ad26.COV2.S-vaccinated adults
err2025-11-10
err0
errOAAI
errMaximilian Schons; Tobias Odendahl; James A. Smith; Kyle Fish; Anemone Franz; Miti Saksena; Sonia Sutherland; Vaughan Reed; Phumzile Mhlongo; Madeli Kruger; Zinhle Zwane; Kgoete Dimakatso; Carol Crowther; Penny Moore; Veronique De Jager; Ethan Alley; Grigory Khimulya
errShare
errSave
A Phase 2a Study of the Early Bactericidal Activity of Rifampicin in Combination With Meropenem Plus Amoxicillin/Clavulanate Among Adults With Rifampicin-Resistant Pulmonary Tuberculosis
err2025-06-01
err0
errOAAI
errde Jager, Veronique; Mockeliunas, Laurynas; You, Huifang; Simonsson, Ulrika S. H.; Collings, Tarryn; Upton, Caryn M.; Bezuidenhout, Johannes A.; Gupte, Nikhil; Dorman, Susan E.; Nuermberger, Eric; Lamichhane, Gyanu; Diacon, Andreas H.; Dooley, Kelly E.
errShare
errSave
Population pharmacokinetics and exposure-response relationship of the antituberculosis drug BTZ-043
err2025-03-01
err0
errOAAI
errKoele, Simon E.; Heinrich, Norbert; De Jager, Veronique R.; Dreisbach, Julia; Phillips, Patrick P. J.; Gross-Demel, Petra; Dawson, Rodney; Narunsky, Kim; Wildner, Leticia M.; Mchugh, Timothy D.; Te Brake, Lindsey H. M.; Diacon, Andreas H.; Aarnoutse, Rob E.; Hoelscher, Michael; Svensson, Elin M.
errShare
errSave
Reporting of molecular test results from cell-free DNA analyses: Expert consensus recommendations from the 2023 European Liquid Biopsy Society ctDNA workshop
err2024-09-01
err0
PREAI
errde Jager, V. D.; Giacomini, P.; Fairley, J.; Toledo, R. D. A.; Patton, S.; Joosse, S.; Koch, C.; Deans, S.; Heitzer, E.; Schuuring, E.
errShare
errSave
High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations A Randomized Phase II Clinical Trial
err2024-08-01
err3
PREAI
errGausi, Kamunkhwala; Ignatius, Elisa H.; De Jager, Veronique; Upton, Caryn; Kim, Soyeon; McKhann, Ashley; Moran, Laura; Wiesner, Lubbe; Von Groote-Bidlingmaier, Florian; Marzinek, Philip; Vanker, Naadira; Yvetot, Joseph; Pierre, Samuel; Rosenkranz, Susan L.; Swindells, Susan; Diacon, Andreas H.; Nuermberger, Eric L.; Denti, Paolo; Dooley, Kelly E.
errShare
errSave
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
err2024-02-16
err6
errOAAI
errDiacon, Andreas H.; Barry, Clifton E., III; Carlton, Alex; Chen, Ray Y.; Davies, Matt; de Jager, Veronique; Fletcher, Kim; Koh, Gavin C. K. W.; Kontsevaya, Irina; Heyckendorf, Jan; Lange, Christoph; Reimann, Maja; Penman, Sophie L.; Scott, Rhona; Maher-Edwards, Gareth; Tiberi, Simon; Vlasakakis, Georgios; Upton, Caryn M.; Aguirre, David Barros
errShare
errSave
Early bactericidal activity of meropenem, ertapenem, amoxicillin/clavulanate and optimized rifampicin in pulmonary tuberculosis
err2023-12-17
err0
errOAAI
errUpton, Caryn; De Jager, Veronique; Simonsson, Ulrika; Mockeliunas, Laurynas; Mabuka, Thabo; Lelievre, Joel; Sharma, Raman; Chen, Chao; Barros, David; Diacon, Andreas
errShare
errSave
Transrenal Mycobacterium tuberculosis DNA in pulmonary tuberculosis patients during the first 14 days of treatment
err2023-12-12
err1
errOAAI
errKontsevaya, Irina; Heyckendorf, Jan; Koops, Frauke; Hillemann, Doris; Goldmann, Torsten; Upton, Caryn M.; De Jager, Veronique; Diacon, Andreas; Lange, Christoph
errShare
errSave
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
err2023-10-18
err3
errOAAI
errStemkens, Ralf; de Jager, Veronique; Dawson, Rodney; Diacon, Andreas H.; Narunsky, Kim; Padayachee, Sherman D.; Boeree, Martin J.; van Beek, Stijn W.; Colbers, Angela; Coenen, Marieke J. H.; Svensson, Elin M.; Fuhr, Uwe; Phillips, Patrick P. J.; te Brake, Lindsey H. M.; Aarnoutse, Rob E.
errShare
errSave
Relative bioavailability of delamanid 50 mg tablets dispersed in water in healthy adult volunteers
err2023-02-11
err3
errOAAI
errZou, Yuanxi; de Jager, Veronique; Hesseling, Anneke C.; Diacon, Andreas H.; Wiesner, Lubbe; Mostert, Joni; Svensson, Elin M.; Garcia-Prats, Anthony
errShare
errSave
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosis
err2022-06-09
err7
errOAAI
errGausi, Kamunkhwala; Chirehwa, Maxwell; Ignatius, Elisa H.; Court, Richard; Sun, Xin; Moran, Laura; Hafner, Richard; Wiesner, Lubbe; Rosenkranz, Susan L.; de Jager, Veronique; de Vries, Nihal; Harding, Joseph; Gumbo, Tawanda; Swindells, Susan; Diacon, Andreas; Dooley, Kelly E.; McIlleron, Helen; Denti, Paolo
errShare
errSave
Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis The COMRADE Randomized, Phase 2A Clinical Trial
err2022-05-15
err23
errOAAI
errDe Jager, Veronique; Gupte, Nikhil; Nunes, Silvia; Barnes, Grace L.; van Wijk, Rob Christiaan; Mostert, Joni; Dorman, Susan E.; Abulfathi, Ahmed A.; Upton, Caryn M.; Faraj, Alan; Nuermberger, Eric L.; Lamichhane, Gyanu; Svensson, Elin M.; Simonsson, Ulrika S. H.; Diacon, Andreas H.; Dooley, Kelly E.
errShare
errSave
Increased bactericidal activity but dose-limiting intolerability at 50 mg.kg-1 rifampicin
err2021-02-04
err22
errOAAI
errte Brake, Lindsey H. M.; de Jager, Veronique; Narunsky, Kim; Vanker, Naadira; Svensson, Elin M.; Phillips, Patrick P. J.; Gillespie, Stephen H.; Heinrich, Norbert; Hoelscher, Michael; Dawson, Rodney; Diacon, Andreas H.; Aamoutse, Rob E.; Boeree, Martin J.
errShare
errSave
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
err2021-02-03
err25
errOAAI
errXie, Yingda L.; de Jager, Veronique R.; Chen, Ray Y.; Dodd, Lori E.; Paripati, Praveen; Via, Laura E.; Follmann, Dean; Wang, Jing; Lumbard, Keith; Lahouar, Saher; Malherbe, Stephanus T.; Andrews, Jenna; Yu, Xiang; Goldfeder, Lisa C.; Cai, Ying; Arora, Kriti; Loxton, Andre G.; Vanker, Naadira; Duvenhage, Michael; Winter, Jill; Song, Taeksun; Walzl, Gerhard; Diacon, Andreas H.; Barry, Clifton E., III
errShare
errSave
Reply to Kim et al., Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment
err2020-06-23
err0
errOAAI
errDiacon, Andreas H.; De Jager, Veronique R.; Dawson, Rodney; Narunsky, Kim; Vanker, Naadira; Burger, Divan A.; Everitt, Daniel; Pappas, Frances; Nedelman, Jerry; Mendel, Carl M.
errShare
errSave
Optimizing β-Lactams against Tuberculosis
err2020-05-01
err8
errOAAI
errde Jager, Veronique R.; Vanker, Naadira; van der Merwe, Lize; van Brakel, Elana; Muliaditan, Morris; Diacon, Andreas H.
errShare
errSave
Telacebec (Q203), a New Antituberculosis Agent
err2020-03-26
err87
errOAAI
errde Jager, Veronique R.; Dawson, Rodney; van Niekerk, Christo; Hutchings, Jane; Kim, Jeongjun; Vanker, Naadira; van der Merwe, Lize; Choi, Jinho; Nam, Kiyean; Diacon, Andreas H.
errShare
errSave
Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis
err2020-03-24
err27
errOAAI
errDiacon, Andreas H.; De Jager, Veronique R.; Dawson, Rodney; Narunsky, Kim; Vanker, Naadira; Burger, Divan A.; Everitt, Daniel; Pappas, Frances; Nedelman, Jerry; Mendel, Carl M.
errShare
errSave
Relative bioavailability of bedaquiline tablets suspended in water: Implications for dosing in children
err2018-08-10
err25
errOAAI
errSvensson, Elin M.; du Bois, Jeannine; Kitshoff, Rene; de Jager, Veronique R.; Wiesner, Lubbe; Norman, Jennifer; Nachman, Sharon; Smith, Betsy; Diacon, Andreas H.; Hesseling, Anneke C.; Garcia-Prats, Anthony J.
errShare
errSave